Oil Surges Past 100 Energy Markets Face Point of No Return Microsoft MSFT A Closer Look at Its Position as a Potential LongTerm Growth Stock CBSE Portal Glitches and Security Concerns Trigger Government Probe Edtech Sector Under Scrutiny Sebi Weighs Margin Rule Revamp to Address AIDriven Cyber Risks in Securities Market EasyJet Assures Summer Flight Schedule Unaffected by Jet Fuel Supply Concerns Amid Iran Tensions Amazon Expands AI Shopping Technology to Retail Partners Signs Kate Spade HRTG Q1 2026 Earnings EPS Misses Estimates as Underwriting Pressures Persist Corvex Inc MOVE Q1 2026 Earnings Loss Narrows as EPS Surprises to the Upside CPSH Q1 2026 Earnings Significant EPS Miss Amidst Stock Surge Unclear Revenue Picture KLTR Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency TUYA Q1 2026 Earnings EPS Slightly Below Estimates Amidst Flat Stock Performance Rapid7 Q1 2026 Earnings EPS Surges Past Estimates Shares Rise on Profitability Beat AngioDynamics ANGO Holds Near Support Amid Modest Uptick Key Levels in Focus OCCIN Preferred Stock Holds Steady at 2476 Trading Near Support Net Lease Office Properties NLOP Edges Higher Testing Key Resistance After 135 Gain Ares Dynamic Credit Allocation Fund ARDC Narrows Slightly as Price Stays Within Defined Range Heritage Commerce Corp HTBK Holds Steady at 1345 as Trading Remains RangeBound GLNG Q1 2026 Earnings EPS Beats Estimates by 1617 as Stock Declines 568 Minnesota Enacts First US State Ban on Prediction Markets Making Operation a Felony ICHR Q1 2026 Earnings EPS Beat Surprises Market Stock Slightly Down Gossamer Bio Inc GOSS Q1 2026 Earnings WiderthanExpected Loss Weighs on Shares Telecom Argentina TEO Q1 2026 Earnings Massive EPS Surprise Drives Positive Market Response Texas Capital Bancshares Inc Series B Preferred TCBIO Q1 2026 Earnings Preferred EPS Surpasses Estimates with 898 Surprise US Payrolls Surge Past Expectations in April Yet Underlying Weaknesses Persist Gen Digital Inc Q1 2026 Earnings EPS Beats Estimates Amidst Mixed Market Reception CorMedix CRMD Tests Support Zone After Modest Decline